SCHEMBL3385938

SCHEMBL3385938

Cc1ccc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1-c1ccc2c(C(=O)O)n[nH]c2c1

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.54
BRAF P15056 3/20 0.49
RAF1 P04049 2/20 0.49
CA9 Q16790 1/20 0.48
TRPV1 Q8NER1 2/20 0.46
AURKB Q96GD4 1/20 0.46
LCK P06239 1/20 0.46
JAK3 P52333 1/20 0.46
MAPK14 Q16539 1/20 0.46
EPHB4 P54760 1/20 0.45
RIPK1 Q13546 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3386109 0.89 KDR (0.50) KDRBRAFRAF1CA9TRPV1
SCHEMBL3384625 0.89 KDR (0.58) KDRBRAFRAF1CA9TRPV1
SCHEMBL3384548 0.88 KDR (0.49) KDRBRAFRAF1CA9LCK
SCHEMBL3387247 0.85 KDR (0.47) KDRBRAFRAF1CA9LCK
SCHEMBL3387701 0.83 FGFR1 (0.51) KDRBRAF
SCHEMBL8739803 0.81 KDR (0.49) KDRBRAFAURKBLCKJAK3
SCHEMBL3387495 0.81 RAF1 (0.53) KDRBRAFRAF1MAPK14
SCHEMBL3386715 0.81 KDR (0.58) KDRBRAFRAF1CA9TRPV1
SCHEMBL3387510 0.80 KDR (0.52) KDRBRAFRAF1CA9AURKB
SCHEMBL3387504 0.78 KDR (0.57) KDRBRAFRAF1TRPV1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed